Immucell Corp /De/ financial data

Symbol
ICCC on Nasdaq
Industry
In Vitro & In Vivo Diagnostic Substances
Location
56 Evergreen Dr, Portland, ME
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2024 - Nov 13, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 273 % -19.9%
Quick Ratio 171 % -9.69%
Debt-to-equity 74 % +26.7%
Return On Equity -15.3 % +32.3%
Return On Assets -8.8 % +38.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 8.91M shares +15%
Common Stock, Shares, Outstanding 8.83M shares +14%
Entity Public Float 31.2M USD -51.6%
Common Stock, Value, Issued 890K USD +13.9%
Weighted Average Number of Shares Outstanding, Basic 8.16M shares +5.39%
Weighted Average Number of Shares Outstanding, Diluted 8.16M shares +5.39%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 6.01M USD +11.4%
Revenue from Contract with Customer, Excluding Assessed Tax 5.4M USD +12.5%
Research and Development Expense 4.15M USD -5.3%
Selling and Marketing Expense 3.3M USD -3.16%
General and Administrative Expense 2.19M USD -0.45%
Operating Income (Loss) -3.27M USD +48.8%
Nonoperating Income (Expense) -125K USD -151%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -3.81M USD +39.6%
Income Tax Expense (Benefit) 5.37K USD +12.1%
Net Income (Loss) Attributable to Parent -3.81M USD +39.5%
Earnings Per Share, Basic -0.5 USD/shares +39%
Earnings Per Share, Diluted -0.5 USD/shares +39%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.32M USD
Cash, Cash Equivalents, and Short-term Investments 11.8M USD +73.6%
Accounts Receivable, after Allowance for Credit Loss, Current 2.31M USD +23.8%
Inventory, Net 7.46M USD +1.01%
Other Assets, Current 57.7K USD -24.8%
Assets, Current 13.9M USD +16.1%
Property, Plant and Equipment, Net 25.8M USD -8.3%
Operating Lease, Right-of-Use Asset 4.59M USD +8.93%
Intangible Assets, Net (Excluding Goodwill) 43K USD -30.8%
Goodwill 95.6K USD 0%
Other Assets, Noncurrent 28.9K USD -58.7%
Assets 44.4M USD -0.22%
Liabilities, Current 4.47M USD +34.2%
Long-term Debt and Lease Obligation 9.42M USD -13.6%
Operating Lease, Liability, Noncurrent 4.15M USD -3.5%
Liabilities 18M USD -2.67%
Retained Earnings (Accumulated Deficit) -14.7M USD -35.1%
Stockholders' Equity Attributable to Parent 26.4M USD +1.53%
Liabilities and Equity 44.4M USD -0.22%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 419K USD
Net Cash Provided by (Used in) Financing Activities -367K USD -149%
Net Cash Provided by (Used in) Investing Activities -70.4K USD +89.7%
Common Stock, Shares Authorized 15M shares 0%
Common Stock, Shares, Issued 8.9M shares +13.9%
Common Stock, Par or Stated Value Per Share 0.1 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.81M USD +91.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 136K USD +55%
Deferred Tax Assets, Valuation Allowance 4.03M USD +48.9%
Deferred Tax Assets, Gross 665K USD +752%
Operating Lease, Liability 4.63M USD +6.05%
Depreciation 2.67M USD +1.59%
Payments to Acquire Property, Plant, and Equipment 70.4K USD -89.7%
Lessee, Operating Lease, Liability, to be Paid 7.88M USD +1.18%
Property, Plant and Equipment, Gross 46.2M USD +0.5%
Operating Lease, Liability, Current 482K USD +611%
Lessee, Operating Lease, Liability, to be Paid, Year Two 350K USD +2%
Lessee, Operating Lease, Liability, to be Paid, Year One 712K USD +111%
Operating Lease, Weighted Average Discount Rate, Percent 0.07 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.25M USD -5.05%
Lessee, Operating Lease, Liability, to be Paid, Year Three 357K USD +2%
Deferred Tax Assets, Operating Loss Carryforwards 3.73M USD +14.5%
Current Income Tax Expense (Benefit) 8.43K USD -26.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 364K USD +2%
Operating Lease, Payments 550K USD +107%
Additional Paid in Capital 36.2M USD +0.9%
Amortization of Intangible Assets 19.1K USD 0%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Share-based Payment Arrangement, Expense 357K USD +7.12%
Interest Expense 585K USD +40.3%